Show simple item record

dc.contributor.authorApplegate, TL
dc.contributor.authorFajardo, E
dc.contributor.authorSacks, JA
dc.date.accessioned2018-06-12T14:56:53Z
dc.date.available2018-06-12T14:56:53Z
dc.date.issued2018-06
dc.date.submitted2018-06-04
dc.identifier.citationHepatitis C Virus Diagnosis and the Holy Grail. 2018, 32 (2):425-445 Infect. Dis. Clin. North Am.en
dc.identifier.issn1557-9824
dc.identifier.pmid29778264
dc.identifier.doi10.1016/j.idc.2018.02.010
dc.identifier.urihttp://hdl.handle.net/10144/619174
dc.description.abstractThe world has embraced the call for global elimination of hepatitis C virus by 2030. The unprecedented speed of therapeutic development and increased access to direct-acting antivirals has made elimination a possibility. We must screen hundreds of millions of people to diagnose and treat those currently infected. Global access to hepatitis C virus diagnostics will be a keystone to success. Key challenges must be overcome and systems optimized to ensure widespread access to existing diagnostics. Although promising technologies may soon transform the landscape, innovative strategies are needed to stimulate investment and accelerate the development of point-of-care hepatitis C virus diagnostics.
dc.language.isoenen
dc.publisherElsevieren
dc.rightsArchived with thanks to Infectious Disease Clinics of North Americaen
dc.titleHepatitis C Virus Diagnosis and the Holy Grailen
dc.identifier.journalInfectious Disease Clinics of North Americaen
refterms.dateFOA2019-03-04T14:01:24Z
html.description.abstractThe world has embraced the call for global elimination of hepatitis C virus by 2030. The unprecedented speed of therapeutic development and increased access to direct-acting antivirals has made elimination a possibility. We must screen hundreds of millions of people to diagnose and treat those currently infected. Global access to hepatitis C virus diagnostics will be a keystone to success. Key challenges must be overcome and systems optimized to ensure widespread access to existing diagnostics. Although promising technologies may soon transform the landscape, innovative strategies are needed to stimulate investment and accelerate the development of point-of-care hepatitis C virus diagnostics.


Files in this item

Thumbnail
Name:
Applegate et al - 2018 - Hepatitis ...
Size:
750.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record